Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Dec;56(6):825–829. doi: 10.1038/bjc.1987.298

Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.

L L Shek 1, W Godolphin 1, J J Spinelli 1
PMCID: PMC2002407  PMID: 3435707

Abstract

The relationship to survival after first recurrence of oestrogen receptor (ER), nodal status and TNM stage at diagnosis, and treatment for advanced disease was studied in 457 females whose primary breast cancer was diagnosed in 1975 to 1981. Receptor concentration was the most important predictor of post-recurrence survival, with some additional information conveyed by nodal status. ER predicted survival after recurrence independently of nodal status, clinical stage or mode of therapy. Response to endocrine therapy is only a facet of the generally favourable prognosis of ER positive patients, rather than the sole explanation.

Full text

PDF
825

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alanko A., Makinen J., Scheinin T. M., Tolppanen E. M., Vihko R. Correlation of estrogen and progesterone receptors and histological grade in human primary breast cancer. Acta Pathol Microbiol Immunol Scand A. 1984 Sep;92(5):311–315. doi: 10.1111/j.1699-0463.1984.tb04409.x. [DOI] [PubMed] [Google Scholar]
  2. Caldarola L., Volterrani P., Caldarola B., Lai M., Jayme A., Gaglia P. The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis. Eur J Cancer Clin Oncol. 1986 Feb;22(2):151–155. doi: 10.1016/0277-5379(86)90024-6. [DOI] [PubMed] [Google Scholar]
  3. Campbell F. C., Blamey R. W., Elston C. W., Nicholson R. I., Griffiths K., Haybittle J. L. Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer. 1981 Sep;44(3):456–459. doi: 10.1038/bjc.1981.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coleman R. E., Rubens R. D. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987 Jan;55(1):61–66. doi: 10.1038/bjc.1987.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crowe J. P., Hubay C. A., Pearson O. H., Marshall J. S., Rosenblatt J., Mansour E. G., Hermann R. E., Jones J. C., Flynn W. J., McGuire W. L. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients. Breast Cancer Res Treat. 1982;2(2):171–176. doi: 10.1007/BF01806453. [DOI] [PubMed] [Google Scholar]
  6. Elwood J. M., Godolphin W. Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients. Br J Cancer. 1980 Nov;42(5):635–644. doi: 10.1038/bjc.1980.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fidler I. J. Recent concepts of cancer metastasis and their implications for therapy. Cancer Treat Rep. 1984 Jan;68(1):193–198. [PubMed] [Google Scholar]
  8. Fisher B. Cancer surgery: a commentary. Cancer Treat Rep. 1984 Jan;68(1):31–41. [PubMed] [Google Scholar]
  9. Godolphin W., Elwood J. M., Spinelli J. J. Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients. Int J Cancer. 1981 Dec;28(6):677–683. doi: 10.1002/ijc.2910280604. [DOI] [PubMed] [Google Scholar]
  10. Godolphin W., Jacobson B. Quality control of estrogen receptor assays. J Immunoassay. 1980;1(3):363–374. doi: 10.1080/01971528008058477. [DOI] [PubMed] [Google Scholar]
  11. Howat J. M., Harris M., Swindell R., Barnes D. M. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer. 1985 Feb;51(2):263–270. doi: 10.1038/bjc.1985.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Howell A., Barnes D. M., Harland R. N., Redford J., Bramwell V. H., Wilkinson M. J., Swindell R., Crowther D., Sellwood R. A. Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet. 1984 Mar 17;1(8377):588–591. doi: 10.1016/s0140-6736(84)90995-4. [DOI] [PubMed] [Google Scholar]
  13. Lionetto R., Pronzato P., Bertelli G. F., Ardizzoni A., Conte P. F., Rosso R. Survival of patients with relapsing breast cancer: analysis of 302 patients. Oncology. 1986;43(5):278–282. doi: 10.1159/000226382. [DOI] [PubMed] [Google Scholar]
  14. Liotta L. A. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol. 1984 Dec;117(3):339–348. [PMC free article] [PubMed] [Google Scholar]
  15. McDivitt R. W., Stone K. R., Craig R. B., Palmer J. O., Meyer J. S., Bauer W. C. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer. 1986 Jan 15;57(2):269–276. doi: 10.1002/1097-0142(19860115)57:2<269::aid-cncr2820570214>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  16. McGuire W. L., Clark G. M., Dressler L. G., Owens M. A. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr. 1986;(1):19–23. [PubMed] [Google Scholar]
  17. Nowell P. C. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
  18. Paterson A. H., Zuck V. P., Szafran O., Lees A. W., Hanson J. Influence and significance of certain prognostic factors on survival in breast cancer. Eur J Cancer Clin Oncol. 1982 Oct;18(10):937–943. doi: 10.1016/0277-5379(82)90241-3. [DOI] [PubMed] [Google Scholar]
  19. Raemaekers J. M., Beex L. V., Koenders A. J., Pieters G. F., Smals A. G., Benraad T. J., Kloppenborg P. W. Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat. 1985;6(2):123–130. doi: 10.1007/BF02235743. [DOI] [PubMed] [Google Scholar]
  20. Ryan E. D., Clark A. F., Mobbs B. G., Ooi T. C., Sutherland D. J., Tustanoff E. R. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols. Clin Biochem. 1985 Feb;18(1):20–26. doi: 10.1016/s0009-9120(85)80018-7. [DOI] [PubMed] [Google Scholar]
  21. Saez S., Cheix F., Asselain B. Prognostic value of estrogen and progesterone receptors in primary breast cancer. Breast Cancer Res Treat. 1983;3(4):345–353. doi: 10.1007/BF01807587. [DOI] [PubMed] [Google Scholar]
  22. Samaan N. A., Buzdar A. U., Aldinger K. A., Schultz P. N., Yang K. P., Romsdahl M. M., Martin R. Estrogen receptor: a prognostic factor in breast cancer. Cancer. 1981 Feb 1;47(3):554–560. doi: 10.1002/1097-0142(19810201)47:3<554::aid-cncr2820470322>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  23. Silverstrini R., Daidone M. G., Di Fronzo G. Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer. 1979 Aug;44(2):665–670. doi: 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  24. Stoll B. A. Mechanisms in endocrine therapy of bone metastases. J R Soc Med. 1985;78 (Suppl 9):11–14. [PMC free article] [PubMed] [Google Scholar]
  25. Williams M. R., Todd J. H., Nicholson R. I., Elston C. W., Blamey R. W., Griffiths K. Survival patterns in hormone treated advanced breast cancer. Br J Surg. 1986 Sep;73(9):752–755. doi: 10.1002/bjs.1800730925. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES